Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Other Non-Current Assets (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Other Non-Current Assets readings, the most recent being $22.9 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 342.62% to $22.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.9 million, a 342.62% increase, with the full-year FY2025 number at $22.9 million, up 342.62% from a year prior.
  • Other Non-Current Assets hit $22.9 million in Q4 2025 for Tandem Diabetes Care, up from $16.5 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $40.3 million in Q4 2023 to a low of $5.2 million in Q4 2024.
  • Median Other Non-Current Assets over the past 5 years was $16.7 million (2021), compared with a mean of $20.5 million.
  • Biggest five-year swings in Other Non-Current Assets: soared 388.37% in 2021 and later plummeted 87.19% in 2024.
  • Tandem Diabetes Care's Other Non-Current Assets stood at $15.7 million in 2021, then surged by 50.25% to $23.6 million in 2022, then soared by 70.69% to $40.3 million in 2023, then plummeted by 87.19% to $5.2 million in 2024, then surged by 342.62% to $22.9 million in 2025.
  • The last three reported values for Other Non-Current Assets were $22.9 million (Q4 2025), $16.5 million (Q3 2025), and $17.3 million (Q2 2025) per Business Quant data.